Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Crystal structures of a type-1 ribosome inactivating protein from Momordica balsamina in the bound and unbound states
Highlights
► The isolated new type 1 ribosome inactivating protein MbRIP-1 is highly toxic. ► Ribose, guanine, ATP and 2′dATP bind to MbRIP-1 at substrate binding site. ► The conformation of active site is unaltered in the complex with ribose. ► The conformation of active site is altered in complexes with guanine and adenine. ► The conformation of active site is further altered when complexed with 2′dATP product.
Introduction
Ribosome inactivating proteins (RIPs) are N-glycosidases (EC. 3.2.2.22) which catalytically hydrolyze N-glycosidic bond between adenine and ribose in highly conserved sarcin/ricin loop of the large subunits of ribosomes [1], [2]. The depurination of this specific adenine results in the prevention of the elongation factor (EF-2) from binding to the large subunits of ribosomes and thus arrests the protein biosynthesis [3]. RIPs are a group of plant toxins and have been classified into three groups according to their structural organizations [4]. Type 1 RIPs, are catalytically active single chain polypeptides with molecular mass ranging from 26 to 31 kDa. Type 2 RIPs with molecular mass ranging from 60 to 65 kDa, consist of two chains, chain A is functionally similar to type 1 RIPs, and is linked through a disulfide bond to lectin-like B chain. Type 3 RIPs are single chain polypeptides containing an extended C-terminal region with an unknown function [5]. The RIPs are known to remove an adenine residue at the 4324th position (according to rat sequence) from the sarcin/ricin loop (SRL) of 28S rRNA of eukaryotic ribosomes. Type 1 RIPs are capable of depurinating both prokaryotic as well as eukaryotic ribosomes [6]. In a contrast, type 2 RIPs have a preference for animal ribosomes [7]. In case of type 3 RIPs, the amino terminal domain resembles with type 1 RIPs. It is linked to an unrelated carboxyl-terminal domain whose function is still unknown [5]. The target site in prokaryotic ribosomes is 2660th adenine residue (according to E. coli sequence) of SRL of 23S rRNA. In addition to SRL, these RIPs also have N-glycosidase activity on other substrates such as, genomic DNA, poly(A)RNA, viral RNA and mRNA [[8], [9]]. It has been suggested that the RIPs have a considerable potential for medicinal applications [10], [11]. They inhibit HIV replication and integration [12], [13] and show specific in vitro and in vivo antitumor activity against breast cancer and melanoma cells [14]. It has been shown to be useful in various clinical conditions [15], [16] while further investigations related to its efficacy against different diseases are required to be pursued. In this regard, it is imperative to examine structures and functions of RIPs from different sources as well as its complexes with various compounds including substrate analogs, substrate products and also structural intermediates. Although structures of type 1 RIPs from several species were known [17], [18], [19], [20], [21], [22], [23], [24], [25], the precise mode of substrate binding and catalytic mechanism was not yet fully understood. Similarly, structures of several type 2 RIPs, whose A chain is structurally and functionally similar to type 1 RIPs, were also known [26], [27], [28], [29] with which a detailed comparison is necessary. We report here crystal structure of a type 1 RIP from Momordica balsamina (MbRIP-1) together with structures of its three complexes, one with ribose sugar, two with free bases guanine and adenine as well as two structures of its complexes with product adenine which was obtained from the crystallization conditions using an RNA substrate adenosine triphosphate (ATP) and a DNA substrate, 2′-deoxyadenosine triphosphate (2′-dATP). These structures have revealed three distinct conformational states of protein representing its unbound state, when bound to free adenine or product adenine from ATP and when bound to product adenine from substrate 2′-dATP. The last structure represents the first RIP structure of a conformational intermediate.
Section snippets
Isolation and purification of a type 1 RIP
The dried seeds of M. balsamina were obtained from local market. The 50 g of seeds was decorticated and pulverized in the presence of liquid nitrogen in a ventilated hood. The 300 ml extraction solution containing 10 mM sodium phosphate buffer (pH 7.5), was added to the ground tissue. The sample was homogenized by Polytron Homogenizer (Cole Parmer Homogenizer, Vernon Hills, USA) for 15 min. The homogenate was stirred for 12 h at 4 °C. In order to remove insoluble particles the homogenate was filtered
Biochemical studies
The purity of samples of MbRIP-1 was established using SDS-PAGE which showed a single band of molecular mass of approximately 30 kDa. The protein was identified as type 1 RIP by determining the sequence of the first 20 amino acid residues, Asp1-Val-Ser-Phe-Arg-Leu-Ser-Gly-Ala-Asp-Pro-Ser-Ser-Tyr-Gly-Met-Phe-Ile-Lys-Asp-Leu20. This sequence showed identities of greater than 90% to other type 1 RIPs such as α-momorcharin [17] and momordin [18]. The complete amino acid sequence (GenBank Accession
Discussion
The active site pocket which is responsible for N-glycosidase activity in type-1 RIPs is situated in a rectangular box formed between two domains. The front wall consists of Tyr70 while back wall is made up of Tyr111. Upper side contains Glu160 and Arg163 while lower part has Glu85 and Gly109. In the unbound state the side chain of Tyr70 is oriented (χ1 = − 66° and χ2 = 165°) to an away position from Glu85 and it is toward Arg163. Its OH group is not involved in any intramolecular hydrogen bond. In
Acknowledgements
The authors acknowledge the financial support from the Department of Science and Technology, New Delhi. TPS thanks the Department of Biotechnology, Govt. of India, New Delhi for the award of Distinguished Biotechnology Research Professorship to him.
References (53)
- et al.
Ribosome-inactivating proteins from plants
Biochim. Biophys. Acta
(1993) - et al.
The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28S ribosomal RNA caused by the toxins
J. Biol. Chem.
(1987) - et al.
RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes
J. Biol. Chem.
(1987) - et al.
Characterization and molecular cloning of a proenzyme form of a ribosome-inactivating protein from maize. Novel mechanism of proenzyme activation by proteolytic removal of a 2.8-kiloDalton internal peptide segment
J. Biol. Chem.
(1991) - et al.
Single-chain ribosome inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA
FEBS Lett.
(1991) - et al.
Immunotoxins in the therapy of cancer: from bench to clinic
Pharmacol. Ther.
(1994) - et al.
A new class of anti-HIV agents: GAP31, DAPs 30 and 32
FEBS Lett.
(1991) - et al.
A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy
Blood
(1993) - et al.
The N-glycosidase mechanism of ribosome-inactivating proteins implied by crystal structures of alpha-momorcharin
Structure
(1994) - et al.
Crystal structure of momordin, a type I ribosome inactivating protein from the seeds of Momordica charantia
FEBS Lett.
(1994)
Atomic resolution structure of cucurmosin, a novel type 1 ribosome-inactivating protein from the sarcocarp of Cucurbita moschata
J. Struct. Biol.
A new activity of anti-HIV and anti-tumor protein GAP31: DNA adenosine glycosidase–structural and modeling insight into its functions
Biochem. Biophys. Res. Commun.
The three-dimensional structure of ricin at 2.8 Ǻ
J. Biol. Chem.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Anal. Biochem.
Cloning of the cDNA of alpha-momorcharin: a ribosome inactivating protein
Biochim. Biophys. Acta
Processing of X-ray diffraction data collected in oscillation mode
Methods Enzymol.
X-ray structure of recombinant ricin A-chain at 1.8 Å resolution
J. Mol. Biol.
X-ray analysis of substrate analogs in the ricin A-chain active site
J. Mol. Biol.
Description, distribution, activity and phylogenetic relationship of ribosome-inactivating proteins in plants, fungi and bacteria
Mini. Rev. Med. Chem.
Ribosome-inactivating proteins from plants: more than RNA N-glycosidases?
FASEB J.
Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA, RNA and poly(A)
Nucleic Acids Res.
A novel mechanism for inhibition of translation by pokeweed antiviral protein: depurination of the capped RNA template
RNA
Antiviral activity of ribosome inactivating proteins in medicine
Mini Rev. Med. Chem.
Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31
Proc. Natl. Acad. Sci. U. S. A.
An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo
Mol. Cancer
Immunotoxins and other conjugates: pre-clinical studies
Mini Rev. Med. Chem.
Cited by (18)
Ribosome inactivating proteins – An unfathomed biomolecule for developing multi-stress tolerant transgenic plants
2022, International Journal of Biological MacromoleculesCitation Excerpt :Of these plant families, Cucurbitaceae members have contributed various RIPs that exhibit significant antifungal properties; for example, α-Benincasin and Hispin from Benincasa hispida controlled Coprinus comatus, and Physalospora piricola, and Fusarium oxysporum, P. piricola and Mycosphaerella arachidicola, respectively (Table 2) [110,111]. Cucurbita moschata RIP inhibits Phytophthora infestans [112], Luffacylin from Luffa cylindrica kills F. oxysporum, M. arachidicola [108], MbRIP-1 from Momordica balsamina controls Aspergillus niger, and Sclerotinia sclerotiorum [113], and α-momorcharin from M. charantia remains effective against Bipolaris maydis, F. graminearum, A. oryzae, and A. niger [114]. TRIP from tobacco, a Solanaceae member, inhibits a wide range of fungal phytopathogens, including Cytospora canker, C. heterostrophus, F. oxysporum and Trichoderma reesei [115].
Atomic-resolution structures of type I ribosome inactivating protein alpha-momorcharin with different substrate analogs
2020, International Journal of Biological MacromoleculesCitation Excerpt :TCS can suppress the occurrence of rice blast disease in transgenic rice [18]. MbRIP (the ribosome inactivating protein from Momordica balsamina), b-32, ricin, PAP, SO6, and RIPs from barley also have antifungal activity [19–24]. Overexpression of b-32 in tobacco plants can enhance the resistance to cotton bollworm [25].
Binding and structural studies of the complexes of type 1 ribosome inactivating protein from Momordica balsamina with cytosine, cytidine, and cytidine diphosphate
2015, Biochemistry and Biophysics ReportsCitation Excerpt :All three compounds bound to MbRIP1 at the active site with dissociation constants of 10−4 M–10−7 M. The orientation of cytosine in the substrate binding cleft is found to be different from that of adenine and guanine in the complexes of MbRIP1 with adenine and guanine [13]. The purification of MbRIP1 was carried out using the protocol reported earlier [13].
Cleavage of nicotinamide adenine dinucleotide by the ribosome-inactivating protein from Momordica charantia
2015, Acta Crystallographica Section:F Structural Biology CommunicationsGenetic modification of crop plants with ribosome-inactivating protein genes for enhanced resistance to pathogens and pests
2023, Journal of Plant Diseases and ProtectionCisgenics and Transgenics: Strategies for Sustainable Crop Development and Food Security
2022, Cisgenics and Transgenics: Strategies for Sustainable Crop Development and Food Security